How do you manage dose titration and nutrition to avoid sarcopenia when prescribing a GLP-1 receptor agonist in a frail older adult with MASLD?

GLP-1 and GLP-1/GIP receptor agonists as a class have been found to be effective in improving MASLD (Loomba et al., PMID 38856224) in patients with and without diabetes. This large class of drugs(more are on the way) also causes significant weight loss, and newer iterations may lower BMI into the no...